MALVERN, PA — Annovis Bio Inc. (NYSE: ANVS) is set to participate in the 13th Alzheimer’s & Parkinson’s Drug Development ...

Parkinson's disease affects around 18,000 people in Ireland and can present with over 40 symptoms. While typically diagnosed ...

2024 — The amount of money people pay out-of-pocket for branded drugs to treat neurological diseases like multiple sclerosis (MS), Alzheimer's, and Parkinson's disease continues to rise, ...

Researchers at McGill University found that a blood test originally designed for Alzheimer’s can predict dementia risk in ...

Scientists have long been racking their brains for ways to treat Alzheimer’s disease, the most common type of dementia.

Scientists at Scripps Research developed a stable form of carnosic acid, which enhanced memory function and improved ...

Tris Pharma announced positive topline results from the ALLEVIATE-2 phase III clinical trial of investigational cebranopadol to treat moderate-to-severe acute pain after bunionectomy surgery. Axonal ...

The herb rosemary has long been linked with memory. "There's rosemary, that's for remembrance," says Ophelia in Shakespeare's ...

Such tests are increasingly moving beyond their origins in cutting-edge research and into the laboratory and diagnostic ...

Hospice use varies depending on whether a person has Parkinson’s disease, Lewy body dementia or Alzheimer’s disease and those with Parkinson’s may have more unmet needs, a new study finds.

A Dominion Hills woman diagnosed with early-onset Parkinson's disease received national recognition last month for her ...

The 13th Alzheimer’s & Parkinson’s Drug Development Summit is the only industry-focused, end-to-end meeting that provides comprehensive coverage from early discovery to late-stage development focused ...